K. Diergarten

Randomized Trial of Two Doses of Taxol in Metastatic Breast Cancer: An Interim Analysis

U. Klaassen, K. Diergarten, H Dittrich et al. · Onkologie · 2009 · 43 citations

Medicine, Oncology, Pharmacology +15

Phase I/II study of the combination of carboplatin and paclitaxel as first-line chemotherapy in patients with advanced epithelial ovarian cancer

Andreas du Bois, Hans‐Joachim Lück, Thomas Bauknecht et al. · Annals of Oncology · 1997 · 42 citations · Full text

Medicine, Gynecology, Oncology +16

345 A multicenter, randomized study of two schedules of paclitaxel (PTX) in patients with advanced breast cancer (ABC)

Tamar Peretz, Aarón Sulkes, P. Chollet et al. · European Journal of Cancer · 1995 · 39 citations

Medicine, Oncology, Pharmacology +10

Phase I study of paclitaxel administered as a 1-hour infusion: toxicity and pharmacokinetics.

H. Maier-Lenz, B. Hauns, B Haering et al. · PubMed · 1997 · 33 citations

Medicine, Pharmacokinetics, Pharmacology +11

Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancer.

Lück Hj, Christoph Thomssen, du Bois A et al. · PubMed · 1997 · 27 citations

Medicine, Oncology, Pharmacology +14